Calendar
Top-down
A look at earnings from the view of macro-economists and market technicians
Market Overview
Heat Map
Sentiment
Technicals
Retail Sales
Pricing
Manu-facturing
Economic Cycle
Bottom-up
A bottom-up view of earnings from professional equity analysts
Earnings Highlights
Date Trades
Earnings News
Pivots
Earnings Cycle
Sector Analysis
Investor
Trader
Support
Documentation, research, and support for the information provided
Indicators
Results
About Us
Library
Contact Us
Plays
Score
Grade
Sign In
Sign In
or
Register
Forgot Password?
OR
Sign in using:
Don't have an account?
Register
RMD
$148.01
Resmed
$3.42
2.37%
RMD
Earnings Whisper ®
N/A
1st Quarter September 2023
Consensus: $1.66
Revenue: $1.08 Bil
Thursday
Nov 2
4:05 PM ET
Score
Grade
Tweet
Share
Watch
Sentiment
Analysts
Sentiment
Analysts
Tweet
Share
Watch
Latest EPS
Thursday, August 3, 2023
ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2023
What do you expect when RMD reports earnings?
Beat
Meet
Miss
Where is RMD's stock price going from here?
Up
Flat
Down
Analysts
Score
Grade
Sentiment
Analysts
Pivots
Resistance
$153.45
$150.86
$149.44
$146.85
Support
$145.42
$142.83
$141.41
Tweet
Trends
Short-term Price
Intermediate-term Price
Long-term Price
Investors' Sentiment
Analysts' Sentiment
Earnings Estimates
Growth
Description
ResMed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market for generators, masks, and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. The company currently has two operating segments, which are the Sleep and Respiratory Care segment and the Software-as-a-Service segment.
Peers
Boston Scientific
Stryker
Abbott
3M
Waters
Teleflex
Baxter International
Becton, Dickinson
Integra LifeSciences Holdings
Merit Medical Systems
Expectations
›
Resmed